469
Views
2
CrossRef citations to date
0
Altmetric
Invited Review

COVID Vaccine-Associated Uveitis

, MD, , MD, PhD, , MD, DMSc, , MD, , MB, BS, , MD, , MD, , BE, , MB, BCh & , MB, BCh, MSc, FRCOphth show all
Pages 1198-1205 | Received 24 Nov 2022, Accepted 03 Apr 2023, Published online: 05 May 2023

References

  • Seah IA, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronavirus and ocular implications in humans and animals. Ocul Immunol Inflammation. 2020;28(3):391–395. doi:10.1080/09273948.2020.1738501.
  • WHO Director-General’s opening remarks at the media briefing on COVID-19. [press release]. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-breifing-on-covid-19—11-march-2020.11. Accessed May 11, 2020.
  • Loon S, Teoh SC, Oon LL, et al. The severe acute respiratory syndrome coronavirus in tears. British J Ophthalmol. 2004;88(7):861–863. doi:10.1136/bjo.2003.035931.
  • Yeo C, Kaushal S, Yeo D, et al. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020;5(4):335–337. doi:10.1016/S2468-1253(20)30048-0.
  • van der Hoek, L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368–373. doi:10.1038/nm1024.
  • Vabret A, Mourez T, Dina J, et al. Human Coronavirus NL63, France. Emerg Infect Dis. 2005;11(8):1225–1229. doi:10.3201/eid1108.050110.
  • Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020;173(3):242–243. doi:10.7326/M20-1176.
  • Lange C, Wolf J, Auw-Haedrich C, et al. Expression of the COVID-19 receptor ACE2 in the human conjunctiva. J Med Virol. 2020;92(10):2081–2086. doi:10.1002/jmv.25981.
  • Vetrugno L, Bove T, Orso D, et al. Our Italian experience using lung ultrasound for identification, grading and serial follow-up of severity of lung involvement for management of patients with COVID-19. Echocardiography (Mount Kisco, NY). 2020;37(4):625–627. doi:10.1111/echo.14664.
  • Diotallevi F, Campanati A, Bianchelli T, et al. Skin involvement in SARS-CoV-2 infection: case series. J Med Virol. 2020;92(11):2332–2334. doi:10.1002/jmv.26012.
  • Asadi-Pooya A, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci Jun. 2020;413:116832. doi:10.1016/j.jns.2020.116832.
  • Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. July 2020;5(7):667–678. doi:10.1016/S2468-1253(20)30126-6.
  • Robbins S, Detrick B, Hooks JJ, et al. Retinopathy following intravitreal injection of mice with MHV strain JHM. Adv Exp Med Biol 276 . 1990;519–524.
  • Neri P, Pichi F. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Int Ophthalmol. 2020;40(5):1057–1060. doi:10.1007/s10792-020-01389-2.
  • Neri P, Lamperti M, Pichi F. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models. Int Ophthalmol. 2020;40(8):1879–1883. doi:10.1007/s10792-020-01495-1.
  • Yao X, Li TY, He ZC, et al. A pathological report of three COVID-19 cases by minimal invasive autopsies]. Zhonghua bing li xue za zhi = Chin J Pathol. 2020;49(5):411–417. doi:10.3760/cma.j.cn112151-20200312-00193.
  • Holder J. Tracking coronavirus vaccinations around the world. The New York Times. 2021.
  • Mascellino M, Di Timoteo F, De Angelis M, Oliva A. Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist. 2021;14:14. doi:10.2147/IDR.S315727.
  • Lancet MFTTa V-CoC. Operation warp speed: implications for global vaccine security - the lancet global health. Lancet Global Health. 2022;9(7):e1017–21. doi:10.1016/S2214-109X(21)00140-6.
  • Cunningham E, Moorthy RS, Fraunfelder FW, Zierhut M. Vaccine-associated uveitis. Ocul Immunol Inflammation. 2019;27(4):517–520. doi:10.1080/09273948.2019.1626188.
  • Haseeb A, Solyman O, Abushanab MM, Abo Obaia AS, Elhusseiny AM. Ocular complications following vaccination for COVID-19: a one-year retrospective. Vaccines (Basel). 2022;10(2):342. doi:10.3390/vaccines10020342.
  • Testi I, Brandão-de-Resende C, Agrawal R, et al. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022;12(1):4. doi:10.1186/s12348-021-00275-x.
  • Lindquist M. VigiBase, the WHO global ICSR database system: basic facts. Drug Inf J. 2008;42(5):409–419. doi:10.1177/009286150804200501.
  • Nanji A, Fraunfelder FT. Anterior uveitis following COVID vaccination: a summary of cases from global reporting systems. Ocul Immunol Inflammation. 2022;30(5):1244–1246. doi:10.1080/09273948.2022.2042316.
  • Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus Pandemic (COVID-19). https://ourworldindata.org/covid-vaccinations:https://ourworldindata.org/coronavirus. 2022.
  • Tomkins-Netzer O, Sar S, Barnett-Griness O, Friedman B, Shyriaieva H, Saliba W. Association between vaccination with the BNT162b2 mRNA coronavirus disease 2019 vaccine and noninfectious uveitis: a population-based study. Ophthalmology. 2022;129(10):1087–1095. doi:10.1016/j.ophtha.2022.05.015.
  • Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. uveitis after the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association. Retina (Philadelphia, Pa). 2021;41(12):2462–2471. doi:10.1097/IAE.0000000000003277.
  • Renisi G, Lombardi A, Stanzione M, Invernizzi A, Bandera A, Gori A. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? Int J Infect Dis. 2021;110:110. doi:10.1016/j.ijid.2021.07.035.
  • Bettach E, Zadok D, Weill Y, Brosh K, Hanhart J. Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection. J Med Virol. 2021;93(1):139–140. doi:10.1002/jmv.26229.
  • Jain A, Kalamkar C. COVID-19 vaccine-associated reactivation of uveitis. Indian J Ophthalmol. 2021;69(10):2899–2900. doi:10.4103/ijo.IJO_1435_21.
  • ElSheikh R, Haseeb A, Eleiwa TK, Elhusseiny AM. Acute uveitis following COVID-19 vaccination. Ocul Immunol Inflammation. 2021;29(6):1207–1209. doi:10.1080/09273948.2021.1962917.
  • Bolletta E, Iannetta D, Mastrofilippo V, et al. Uveitis and other ocular complications following COVID-19 Vaccination. J Clin Med. 2021;10(24):5960. doi:10.3390/jcm10245960.
  • Alhamazani M, Alruwaili WS, Alshammri B, Alrashidi S, Almasaud J. A case of recurrent acute anterior uveitis after the administration of COVID-19 vaccine. Cureus. 2022;14(3):22911. doi:10.7759/cureus.22911.
  • Hwang C, Steigleman WA, Saucedo-Sanchez E, Tuli SS. Reactivation of herpes zoster keratitis in an adult after varicella zoster vaccination. Cornea. 2013;32(4):508–509. doi:10.1097/ICO.0b013e318277acae.
  • Matsuo T, Honda H, Tanaka T, Uraguchi K, Kawahara M, Hagiya H. COVID-19 mRNA vaccine–associated uveitis leading to diagnosis of sarcoidosis: case report and review of literature. J Investig Med High Impact Case Rep. 2022;10:10. doi:10.1177/23247096221086450.
  • Chen X, Li X, Li H, Li M, Gong S. Ocular adverse events after inactivated COVID-19 vaccination in Xiamen. Vaccines (Basel). 2022;10(3):482. doi:10.3390/vaccines10030482.
  • Ferrand N, Accorinti M, Agarwal M, et al. COVID-19 vaccination and uveitis: epidemiology, clinical features and visual prognosis. Ocul Immunol Inflammation. 2022;30(5):1265–1273. doi:10.1080/09273948.2022.2058964.
  • Rallis K, Fausto R, Ting DSJ, Al-Aqaba MA, Said DG, Dua HS. Manifestation of herpetic eye disease after COVID-19 vaccine: a UK case series. Ocul Immunol Inflammation. 2022;30(5):1136–1141. doi:10.1080/09273948.2022.2046795.
  • Bhavsar K, Lin S, Rahimy E, et al. Acute macular neuroretinopathy: a comprehensive review of the literature. Surv Ophthalmol. 2016;61(5):538–565. doi:10.1016/j.survophthal.2016.03.003.
  • Drüke D, Pleyer U, Hoerauf H, Feltgen N, Bemme S. Acute macular neuroretinopathy (AMN) following COVID-19 vaccination. Am J Ophthalmol Case Rep. 2021;24:24. doi:10.1016/j.ajoc.2021.101207.
  • Bøhler A, Strøm ME, Sandvig KU, Moe MC, Jørstad ØK. Acute macular neuroretinopathy following COVID-19 vaccination. Eye. 2021;36(3):644–645. doi:10.1038/s41433-021-01610-1.
  • Book B, Schmidt B, Foerster AMH, et al. Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA Ophthalmol. 2022;139(7):e212471. doi:10.1001/jamaophthalmol.2021.2471.
  • Mambretti M, Huemer J, Torregrossa G, Ullrich M, Findl O, Casalino G. Acute macular neuroretinopathy following coronavirus disease 2019 vaccination. Ocul Immunol Inflammation. 2021;29(4):730–733. doi:10.1080/09273948.2021.1946567.
  • Michel T, Stolowy N, Gascon P, et al. Acute macular neuroretinopathy after COVID-19 vaccine. J Français d’Ophtalmol. 2022;45(7):299–302. doi:10.1016/j.jfo.2022.01.022.
  • Vinzamuri S, Pradeep TG, Kotian R. Bilateral paracentral acute middle maculopathy and acute macular neuroretinopathy following COVID-19 vaccination. Indian J Ophthalmol. 2021;69(10):2862–2864. doi:10.4103/ijo.IJO_1333_21.
  • Gabrielle P, Baudin F, Ghezala IB, et al. Bilateral acute macular neuroretinopathy in a young woman after the first dose of Oxford–AstraZeneca COVID-19 vaccine. Am J Ophthalmol Case Rep. 2022;25:101281. doi:10.1016/j.ajoc.2022.101281.
  • Hooper LC, Chin MS, Detrick B, Hooks JJ. Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-α, soluble TNFR2 and altered TNF-α signaling. J Neuroimmunol. September 2005;166(1–2):65–74. doi:10.1016/j.jneuroim.2005.05.018.
  • Tsui I, Sarraf D. Paracentral acute middle maculopathy and acute macular neuroretinopathy. Ophthalmic Surgery Lasers Imaging Retina. 2013;44(6 (Suppl)):S33–35. doi:10.3928/23258160-20131101-06.
  • Madendag Y, Acmaz G, Atas M, et al. The effect of oral contraceptive pills on the macula, the retinal nerve fiber layer, and choroidal thickness. Med Sci Monit. 2017;23:5657–5661. doi:10.12659/MSM.905183.
  • Ng X, Betzler BK, Testi I, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflammation. 2021;29(6):1216–1224. doi:10.1080/09273948.2021.1976221.
  • Hwang C, Sen HN. Concurrent vascular flow defects at the deep capillary plexus and choriocapillaris layers in acute macular neuroretinopathy on multimodal imaging: a case series. Am J Ophthalmol Case Rep. 2020;20:20. doi:10.1016/j.ajoc.2020.100866.
  • Ma D. Acute Posterior Multifocal Placoid Pigment Epitheliopathy 1ed. Yu H, ed. Vol. VII. Springer Singapore; 2020:220.
  • Jakirlic N, Harris T. Case report: acute posterior multifocal placoid pigment epitheliopathy after SARS-CoV-2 vaccination. Optom Vis Sci. 2022;99(6):534–539. doi:10.1097/OPX.0000000000001900.
  • Ramakrishnan M, Patel AP, Melles R, Vora RA. Multiple evanescent white dot syndrome: findings from a large Northern California Cohort. Ophthalmol Retina. 2021;5(9):850–854. doi:10.1016/j.oret.2020.11.016.
  • Papasavvas I, Mantovani A, Tugal-Tutkun I, Herbort CP. Multiple evanescent white dot syndrome (MEWDS): update on practical appraisal, diagnosis and clinicopathology; a review and an alternative comprehensive perspective. J Ophthalmic Inflamm Infect. 2021;11(1):45. doi:10.1186/s12348-021-00279-7.
  • Herbort C Jr. Multiple Evanescent White Dot Syndrome (MEWDS). Zierhut M, Pavésio, C., Ohno, S., et al, eds. Vol. XXIII. Berlin, Heidelberg: Springer; 2021:1609.
  • Mantovani A, Invernizzi A, Staurenghi G, Herbort CP. Multiple evanescent white dot syndrome: a multimodal imaging study of foveal granularity. Ocul Immunol Inflammation. 2019;27(1):141–147. doi:10.1080/09273948.2017.1353104.
  • Tomishige K, Novais EA, Finamor LPDS, Nascimento HMD, Belfort R Jr. Multiple evanescent white dot syndrome (MEWDS) following inactivated COVID-19 vaccination (Sinovac-CoronaVac). Arq Bras Oftalmol. 2022;85(2):186–189. doi:10.5935/0004-2749.20220070.
  • Inagawa S, Onda M, Miyase T, et al. Multiple evanescent white dot syndrome following vaccination for COVID-19: a case report. Medicine. 2022;101(2):28582. doi:10.1097/MD.0000000000028582.
  • Goyal M, Murthy SI, Annum S. Bilateral multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflammation. 2021;29(4):7753–7757. doi:10.1080/09273948.2021.1957123.
  • Pan L, Zhang Y, Cui Y, Wu X. Bilateral uveitis after inoculation with COVID-19 vaccine: a case report. Int J Infect Dis. 2021;113:116–118. doi:10.1016/j.ijid.2021.09.075.
  • Arora A, Handa S, Singh SR, et al. Recurrence of tubercular choroiditis following anti-SARS-CoV-2 vaccination. Eur J Ophthalmol. 2022:112067212210884. doi:10.1177/11206721221088439.
  • Mudie L, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocul Immunol Inflammation. 2021;29(4):741–742. doi:10.1080/09273948.2021.1949478.
  • Sonoda K, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021;65(2):184–190. doi:10.1007/s10384-020-00809-1.
  • Nakayama M, Keino H, Watanabe T, Okada AA. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. British J Ophthalmol. 2019;103(2):274–278. doi:10.1136/bjophthalmol-2017-311691.
  • Kim M. Vogt-Koyanagi-Harada syndrome following influenza vaccination. Indian J Ophthalmol. 2016;64(1):98. doi:10.4103/0301-4738.178141.
  • Sood A, O’Keefe G, Bui D, Jain N. Vogt-Koyanagi-Harada disease associated with Hepatitis B Vaccination. Ocul Immunol Inflammation. 2019;27(4):524–527. doi:10.1080/09273948.2018.1483520.
  • Kong K, Ding X, Ni Y. Resolution of Harada disease-like uveitis after quadrivalent human papillomavirus vaccination: a case report. Hum Vaccines Immunother. 2022;18(1):1–4. doi:10.1080/21645515.2021.1953349.
  • Campos W, Cenachi SPF, Soares MS, Gonçalves PF, Vasconcelos-Santos DV. Vogt-Koyanagi-Harada -like disease following yellow fever Vaccination. Ocul Immunol Inflammation. 2021;29(1):124–127. doi:10.1080/09273948.2019.1661498.
  • Saraceno J, Souza GM, dos Santos Finamor LP, Nascimento HM, Belfort R. Vogt-Koyanagi-Harada syndrome following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. Int J Retina Vitreous. 2021;7(1):1–7. doi:10.1186/s40942-021-00319-3.
  • Koong L, Chee WK, Toh ZH, Ng XL, Agrawal R, Ho SL. Vogt-Koyanagi-Harada disease associated with COVID-19 mRNA vaccine. Ocul Immunol Inflammation. 2021;29(6):1212–1215. doi:10.1080/09273948.2021.1974492.
  • Accorinti M, Saturno MC, Manni P. Vogt-Koyanagi-Harada relapse after COVID-19 vaccination. Ocul Immunol Inflammation. 2022;30(5):1228–1233. doi:10.1080/09273948.2022.2027469.
  • Nakayama M, Okada AA, Hayashi I, Keino H COVID-19 vaccination-related intraocular inflammation in Japanese patients. Graefes Arch Clin Exp Ophthalmol. 2022 ( Online ahead of print)
  • Japanese Ocular Inflammation Society. Japanese language. https://ec9fd949-c894-4a1a-b830-54a6a14acd46.usrfiles.com/ugd/ec9fd9_4eedf51f295845a9b11b30176e285815.pdf. Accessed July 2, 2022
  • Maleki A, Look-Why S, Manhapra A, Stephen Foster C. COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or coincidence? J Ophthalmic Vision Res. 2021;16(3):490–501. doi:10.18502/jovr.v16i3.9443.
  • Iwai S, Takayama K, Sora D, Takeuchi M. A case of acute retinal necrosis associated with reactivation of varicella zoster virus after COVID-19 vaccination. Ocul Immunol Inflammation. 2021;31(1):1–3. doi:10.1080/09273948.2021.2001541.
  • Alkhalifah M, Alsobki HE, Alwael HM, Al Fawaz AM, Al-Mezaine HS. Herpes simplex virus keratitis reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: a report of two cases. Ocul Immunol Inflammation. 2021;29(6):1238–1240. doi:10.1080/09273948.2021.1986548.
  • Song M, Koh KM, Hwang KY, Kwon YA, Kim KY. Relapsed disciform stromal herpetic keratitis following mRNA COVID-19 vaccination: a case report. Korean J Ophthalmol. 2022;36(1):80–82. doi:10.3341/kjo.2021.0150.
  • Cohen S, Olshaker H, Fischer N, et al. Herpetic eye disease following the SARS-CoV-2 vaccinations. Ocul Immunol Inflammation. 2022:1–12. doi:10.1080/09273948.2022.2103831.
  • Lo T, Varma S, Shaw A, Michalova K. Varicella zoster reactivation causing acute retinal necrosis following mRNA COVID-19 vaccination in a young immunocompetent man. Ocul Immunol Inflammation. 2022;31(3):1–4. doi:10.1080/09273948.2022.2033795.
  • Mishra S, Mahendradas P, Kawali A, Sanjay S, Shetty R. Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID-19 vaccination in an Asian Indian male. Eur J Ophthalmol. 2021;33(1):NP32–36. doi:10.1177/11206721211046485.
  • Sanjay S, Ponnuru D, Kumar S, R Rao V, Kawali A, Mahendradas P. Herpes zoster reactivation after COVID-19 vaccination in patients with autoimmune diseases. Indian J Rheumatol. 2022;17(2):216–221. doi:10.4103/injr.injr_137_21.
  • Sangoram R, Mahendradas P, Mishra SB, Kawali A, Sanjay S, Shetty R. Herpes simplex virus 1 anterior uveitis following coronavirus disease 2019 (COVID-19) vaccination in an Asian Indian female. Ocul Immunol Inflammation. 2022;30(5):1260–1264. doi:10.1080/09273948.2022.2055580.
  • Singh J, More A, Shetty SB, Chaskar P, Sen A. Herpes simplex virus retinitis following ChAdOx1 nCoV- 19 (Covishield) vaccination for SARS CoV 2: a case report. Ocul Immunol Inflammation. 2022;30(5):1282–1285. doi:10.1080/09273948.2022.2069127.
  • Papasavvas I, de Courten C, Herbort CP. Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination - report of three cases. J Ophthalmic Inflamm Infect. 2021;11(1):28. doi:10.1186/s12348-021-00260-4.
  • Herbort C, Papasavvas I. Effect of SARS-CoV-2 mRNA vaccination on ocular herpes simplex and varicella-zoster virus reactivation: should preventive antiviral treatment be given in known herpes patients. J Ophthalmic Inflamm Infect. 2021;11(1):33. doi:10.1186/s12348-021-00262-2.
  • Li S, Jia X, Yu F, Wang Q, Zhang T, Yuan J. Herpetic Keratitis Preceded by COVID-19 Vaccination. Vaccines (Basel). 2021;9(12):1394. doi:10.3390/vaccines9121394.
  • Agarwal M, Dutta Majumder P, Babu K, et al. Drug-induced uveitis: a review. Indian, J Ophthalmol. 2020;68(9):1799–1807. doi:10.4103/ijo.IJO_816_20.
  • Cunningham ET Jr, Moorthy RS. Vaccine-associated posterior uveitis. Retina. 2020;40(4):595–598. doi:10.1097/IAE.0000000000002816.
  • Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA Ophthalmol. October 1, 2021;139(10):1131–1135. doi:10.1001/jamaophthalmol.2021.3477. PMID: 34473209; PMCID: PMC8414361.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.